 Medtronic Inc said its experimental medical device for the treatment of high blood pressure failed to provide a benefit compared with a placebo procedure in a large clinical study casting uncertainty over the future of a technology that Medtronic and other device makers have touted as a potentially large source of revenue growth in the years to come Medtronic said that it will stop enrolling new patients with hypertension in other clinical trials of the device called the Symplicity Renal Denervation System after finding
  